Clinical Update

Clinical Update

  • Passive Exposure to Marijuana

    Q:  My patient’s Aegis report returned positive for marijuana, and they are citing passive exposure to marijuana as the cause. Is this possible? A: It…

  • Hydrochlorothiazide Reporting

    Q:  I received a report that listed Chlorothiazide (CTZ)/Hydrochlorothiazide (HCTZ) as present. Why are these two medications reported together? A: CTZ…

  • Gabapentin Abuse

    Q:  I have recently heard reports of gabapentin abuse. Is gabapentin a widely abused drug? A: Although gabapentin is not a federally controlled substance,…

  • Keeping up with Ketamine

    Keeping up with Ketamine

    Q:  Recently, I have heard of ketamine (Ketalar®) being used for the treatment of depression or pain. Can ketamine be used for these indications, and are…

  • Pass or fail? Will cannabidiol oil test positive for marijuana?

    Q. My patient tested positive for marijuana (THC) on an Aegis urine drug test after reporting use of a cannabidiol (CBD) oil product. Is this possible? A.…

  • Grapefruit-Drug Interactions

    Q: What is the significance of grapefruit-drug interactions, and how can I most effectively detect if a patient is at risk for negative therapeutic outcomes…

  • Leverage Objective Information to Identify Interactions Between Opioid Analgesics and Antidepressants

    Q: Many of my patients requiring opioid analgesic therapy are also taking medications commonly used to treat depression, anxiety, and other psychological…